in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
BioAmber prices shares for IPO
11:25 AM MDT | April 15, 2013 | Rebecca Coons
Biobased succinic acid producer BioAmber said last week it aims to raise $128 million with its planned initial public offering. In an SEC filing dated 12 April, the company said it would sell 8 million shares at $15–17 million. The $128-million target is a modest discount to its original target of raising $150-million, used when the company first announced plans for an IPO in November 2011. A number of its peers in the biobased chemicals industry, including Elevance Renewable Sciences (Woodbridge, IL), Genomatica (San Diego), and Coskata (Warrenville...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee